US2018016332A1PendingUtilityA1
Compositions and methods for growth factor modulation
Est. expiryMay 6, 2033(~6.8 yrs left)· nominal 20-yr term from priority
A61P 43/00A61P 9/00A61P 9/10A61P 7/00A61P 3/10A61P 37/02A61P 35/00A61P 31/04A61P 31/00A61P 29/00A61P 21/02A61P 21/00A61P 19/02A61P 25/00A61P 11/00A61P 13/12A61P 17/00A61P 1/16A61P 17/02C07K 2317/31G01N 2333/71C12N 15/1037A61K 38/00C07K 16/2863C07K 16/22C07K 2317/565A61K 39/3955C07K 2317/32G01N 2333/495C07K 14/495C07K 16/005C07K 2317/94C07K 2317/24C07K 2317/76C07K 2317/21C07K 16/28C07K 2317/55C07K 2317/92C07K 2317/33A61K 39/001134
66
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
Provided herein are proteins, antibodies, assays and methods useful for modulating growth factor levels and/or activities. In some embodiments, such growth factors are members of the TGF-β superfamily of proteins.
Claims
exact text as granted — not AI-modified1 .- 11 . (canceled)
12 . An isolated monoclonal antibody, or a fragment thereof, that binds a growth factor prodomain complex (GPC),
wherein said GPC comprises a GDF-8 growth factor and a GDF-8 prodomain (SEQ ID NO: 70), wherein the antibody or fragment thereof does not bind a mature GDF-8 growth factor, a mature GDF-11 growth factor, a GDF-11 prodomain or a complex comprising a GDF-11 prodomain and a GDF-11 growth factor, and wherein said antibody, or fragment thereof, inhibits the release of said mature GDF-8 growth factor from the GPC.
13 . The antibody of claim 12 , wherein said prodomain has not been cleaved at the BMP/tolloid cleavage site between residues Arg 75 and Asp 76 of the GDF-8 prodomain.
14 . The antibody of claim 12 , wherein said antibody is an IgG antibody.
15 . The antibody of claim 14 , wherein said IgG antibody is a human or humanized antibody.
16 . The antibody of claim 12 , wherein said antibody prevents the proteolytic cleavage by at least one metalloproteinase.
17 . The antibody of claim 16 , wherein said metalloproteinase is mammalian tolloid-like 2 (mTLL2).
18 . The antibody of claim 12 , wherein said antibody recognizes an epitope within the GDF-8 arm region of the GDF-8 prodomain set forth in SEQ ID NO: 77.
19 . The antibody of claim 12 , wherein said GDF-8 prodomain has not been cleaved at a furin cleavage site.
20 . The antibody of claim 12 , wherein said GDF-8 prodomain has been cleaved at a furin cleavage site.
21 . The antibody of claim 20 , wherein said furin cleavage site is Arg-Ser-Arg-Arg set forth in SEQ ID NO: 76.Cited by (0)
No later patents cite this yet.
References (0)
No backward citations on record.